PGP and cancer: This finding indicates that the P-gp inhibitory activity of TCZ, itraconazole, and posaconazole primarily contributes to their highly cytotoxic effect on P-gp-overexpressing drug-resistant KBV20C and MCF-7/ADR cancer cells treated with antimitotic drugs.